Exchange: NASDAQ·Updated 10:33 AM EDT
ANNX logo

ANNX Annexon Inc

$4.88
$0.09
(1.81%)
Today
Reported EarningsAug 12
Mkt Cap$942.21M
Vol286,381.00

About ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
39

Bearish Sentiment

How do you feel about ANNX?

Advertisement|Remove ads.